Market research
067630.KO HLB Life Science Co.Ltd
KO KRW Other
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- nan%
- Beta
- Not available
Profile
Company facts
- Exchange
- KO
- Currency
- KRW
- Sector
- Other
- Industry
- Other
- ISIN
- KR7067630004
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- nan%
- Beta
- Not available
- MarketCapitalization
- Not available
About
About HLB Life Science Co.Ltd
A company description is not available for this instrument.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 067630.KO discussion.
5 years, 4 months ago
HLB Life Science Co.Ltd is currently in a long term downtrend where the price is trading 47.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
HLB Life Science Co.Ltd's total revenue sank by 31.9% to $19B since the same quarter in the previous year.
Its net income has dropped by 373.4% to $-44B since the same quarter in the previous year.
Finally, its free cash flow grew by 103.0% to $112M since the same quarter in the previous year.
Based on the above factors, HLB Life Science Co.Ltd gets an overall score of 2/5.